[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc. (REGN): Among the Stocks That Will Go to The Moon According to Analysts",
    "summary": "We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other stocks. The Stock Market Under Trump Admin While stocks initially fell based on worries regarding Trump tariffs on […]",
    "url": "https://finnhub.io/api/news?id=15fd8c457779b2f107fb19894c071db68b9834d285a31d050bf4d3565ef54a6a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740504371,
      "headline": "Regeneron Pharmaceuticals, Inc. (REGN): Among the Stocks That Will Go to The Moon According to Analysts",
      "id": 133186702,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other stocks. The Stock Market Under Trump Admin While stocks initially fell based on worries regarding Trump tariffs on […]",
      "url": "https://finnhub.io/api/news?id=15fd8c457779b2f107fb19894c071db68b9834d285a31d050bf4d3565ef54a6a"
    }
  },
  {
    "ts": null,
    "headline": "REGN Deadline: REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit",
    "summary": "NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. between November 2, 2023 and October 30,...",
    "url": "https://finnhub.io/api/news?id=ec14cd730e3dbb3008af95c5167a0abb23c6aefb0e60af1c1a808b22874fb0a8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740502877,
      "headline": "REGN Deadline: REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit",
      "id": 132873411,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. between November 2, 2023 and October 30,...",
      "url": "https://finnhub.io/api/news?id=ec14cd730e3dbb3008af95c5167a0abb23c6aefb0e60af1c1a808b22874fb0a8"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=c13a7f3078f1729ca098d8c4f9c114feb54ee5339e47b1326be8271b37b515bb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740501720,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "id": 132886655,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=c13a7f3078f1729ca098d8c4f9c114feb54ee5339e47b1326be8271b37b515bb"
    }
  },
  {
    "ts": null,
    "headline": "Pomerantz Law Firm Announces the Filing of a Class Action Against Regeneron Pharmaceuticals, Inc. - REGN",
    "summary": "NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc.  . Such investors are advised to contact Danielle...",
    "url": "https://finnhub.io/api/news?id=e7fc1132faffba730e79aacc3bd4e511e7807e94ba3bc8dcbf1a1a597285cc96",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740501558,
      "headline": "Pomerantz Law Firm Announces the Filing of a Class Action Against Regeneron Pharmaceuticals, Inc. - REGN",
      "id": 132873286,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc.  . Such investors are advised to contact Danielle...",
      "url": "https://finnhub.io/api/news?id=e7fc1132faffba730e79aacc3bd4e511e7807e94ba3bc8dcbf1a1a597285cc96"
    }
  },
  {
    "ts": null,
    "headline": "Big Pipeline Updates From Kiniksa Pharmaceuticals",
    "summary": "Kiniksa is shifting to next-gen IL-1 antibodies for recurrent pericarditis. Click here to read more on how this impacts KNSA stock in 2025 and beyond.",
    "url": "https://finnhub.io/api/news?id=eb216098eab1a82abe31410796add4295d490556b8847e2e4dd9f41052a78823",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740500046,
      "headline": "Big Pipeline Updates From Kiniksa Pharmaceuticals",
      "id": 132873156,
      "image": "https://static.seekingalpha.com/uploads/2025/2/25/4987661-17404994967854137_origin.png",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Kiniksa is shifting to next-gen IL-1 antibodies for recurrent pericarditis. Click here to read more on how this impacts KNSA stock in 2025 and beyond.",
      "url": "https://finnhub.io/api/news?id=eb216098eab1a82abe31410796add4295d490556b8847e2e4dd9f41052a78823"
    }
  },
  {
    "ts": null,
    "headline": "First Circuit Clarifies \"Resulting From\" Standard Under Anti-Kickback Statute, Reshaping False Claims Act Litigation",
    "summary": "The United States Court of Appeals for the First Circuit issued a pivotal ruling earlier this week, finding that in order to establish falsity in a False Claims Act case premised on Anti-Kickback...",
    "url": "https://finnhub.io/api/news?id=25eb8de78f9f2653fe03ddc864b639c9853ebf2c8fb0df2ada77b1d9acfe490c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740467350,
      "headline": "First Circuit Clarifies \"Resulting From\" Standard Under Anti-Kickback Statute, Reshaping False Claims Act Litigation",
      "id": 132869930,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "The United States Court of Appeals for the First Circuit issued a pivotal ruling earlier this week, finding that in order to establish falsity in a False Claims Act case premised on Anti-Kickback...",
      "url": "https://finnhub.io/api/news?id=25eb8de78f9f2653fe03ddc864b639c9853ebf2c8fb0df2ada77b1d9acfe490c"
    }
  },
  {
    "ts": null,
    "headline": "Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - REGN",
    "summary": "NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. of a class action securities lawsuit. ...",
    "url": "https://finnhub.io/api/news?id=ea34027120710c3e48cd46ac3f95566a403a4817876a2d483fa475ab4c16c184",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740462379,
      "headline": "Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - REGN",
      "id": 132869356,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. of a class action securities lawsuit. ...",
      "url": "https://finnhub.io/api/news?id=ea34027120710c3e48cd46ac3f95566a403a4817876a2d483fa475ab4c16c184"
    }
  }
]